168 related articles for article (PubMed ID: 15823610)
1. Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases.
Operario DJ; Reynolds HM; Kim B
Virology; 2005 Apr; 335(1):106-21. PubMed ID: 15823610
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
Auwerx J; Esnouf R; De Clercq E; Balzarini J
Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus.
Chen H; McBroom DG; Zhu YQ; Gold L; North TW
Biochemistry; 1996 May; 35(21):6923-30. PubMed ID: 8639644
[TBL] [Abstract][Full Text] [Related]
4. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis.
Weiss KK; Chen R; Skasko M; Reynolds HM; Lee K; Bambara RA; Mansky LM; Kim B
Biochemistry; 2004 Apr; 43(15):4490-500. PubMed ID: 15078095
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a novel nested PCR for the routine diagnosis of feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV).
Arjona A; Barquero N; Doménech A; Tejerizo G; Collado VM; Toural C; Martín D; Gomez-Lucia E
J Feline Med Surg; 2007 Feb; 9(1):14-22. PubMed ID: 16863698
[TBL] [Abstract][Full Text] [Related]
6. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
7. Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases.
Amacker M; Hübscher U
J Mol Biol; 1998 May; 278(4):757-65. PubMed ID: 9614940
[TBL] [Abstract][Full Text] [Related]
8. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
[TBL] [Abstract][Full Text] [Related]
9. Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.
Auwerx J; North TW; Preston BD; Klarmann GJ; De Clercq E; Balzarini J
Mol Pharmacol; 2002 Feb; 61(2):400-6. PubMed ID: 11809865
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic differences in RNA-dependent DNA polymerization and fidelity between murine leukemia virus and HIV-1 reverse transcriptases.
Skasko M; Weiss KK; Reynolds HM; Jamburuthugoda V; Lee K; Kim B
J Biol Chem; 2005 Apr; 280(13):12190-200. PubMed ID: 15644314
[TBL] [Abstract][Full Text] [Related]
11. Template-independent DNA synthesis activity associated with the reverse transcriptase of the long terminal repeat retrotransposon Tf1.
Oz-Gleenberg I; Herzig E; Hizi A
FEBS J; 2012 Jan; 279(1):142-53. PubMed ID: 22035236
[TBL] [Abstract][Full Text] [Related]
12. Intramolecular chimeras of the p51 subunit between HIV-1 and FIV reverse transcriptases suggest a stabilizing function for the p66 subunit in the heterodimeric enzyme.
Tasara T; Amacker M; Hübscher U
Biochemistry; 1999 Feb; 38(5):1633-42. PubMed ID: 9931031
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic and therapeutic effects of phosphonoformate against feline leukemia virus in vitro.
Swenson CL; Polas PJ; Cheney CM; Kociba GJ; Mathes LE
Am J Vet Res; 1991 Dec; 52(12):2010-5. PubMed ID: 1724122
[TBL] [Abstract][Full Text] [Related]
14. Glycan moiety modifications of feline alpha1-acid glycoprotein in retrovirus (FIV, FeLV) affected cats.
Pocacqua V; Provasi E; Paltrinieri S; Gelain E; Comunian C; Ceciliani F
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):17-26. PubMed ID: 15982476
[TBL] [Abstract][Full Text] [Related]
15. Retroviral reverse transcriptases (other than those of HIV-1 and murine leukemia virus): a comparison of their molecular and biochemical properties.
Hizi A; Herschhorn A
Virus Res; 2008 Jun; 134(1-2):203-20. PubMed ID: 18291546
[TBL] [Abstract][Full Text] [Related]
16. Antibody response to reverse transcriptase in cats infected with feline immunodeficiency virus.
Fevereiro M; Roneker C; de Noronha F
Viral Immunol; 1991; 4(4):225-35. PubMed ID: 1726399
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of FIV-pPPR, a pathogenic molecular clone of feline immunodeficiency virus, and two drug-resistant pol gene mutants.
McCrackin Stevenson MA; McBroom DG
Am J Vet Res; 2001 Apr; 62(4):588-94. PubMed ID: 11327469
[TBL] [Abstract][Full Text] [Related]
18. Secondary structure in the 3' UTR of EGF and the choice of reverse transcriptases affect the detection of message diversity by RT-PCR.
Brooks EM; Sheflin LG; Spaulding SW
Biotechniques; 1995 Nov; 19(5):806-12, 814-5. PubMed ID: 8588921
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Moloney murine leukaemia virus/avian myeloblastosis virus chimeric reverse transcriptases.
Yasukawa K; Mizuno M; Inouye K
J Biochem; 2009 Mar; 145(3):315-24. PubMed ID: 19060310
[TBL] [Abstract][Full Text] [Related]
20. The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication.
Prabhu S; Lobelle-Rich PA; Levy LS
Virology; 1999 Oct; 263(2):460-70. PubMed ID: 10544118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
